Form 4: Natural Alternatives International Director Alan G. Dunn Receives 8,000 Shares of Restricted Stock

Sentiment:

SEC Form 4 Filing


Director Alan G. Dunn acquired 8,000 shares of restricted stock in Natural Alternatives International Inc. on March 7, 2025, as part of the company's 2020 Omnibus Incentive Plan.

Summary

  • Alan G. Dunn, a director at Natural Alternatives International Inc. (NAII), acquired 8,000 shares of common stock on March 7, 2025.
  • The acquisition was a grant of restricted stock under the company's 2020 Omnibus Incentive Plan.
  • The shares were granted at a price of $0.
  • One-third of the shares (2,667) will vest on March 7, 2026, another third (2,667) on March 7, 2027, and the final third (2,666) on March 7, 2028.
  • Following the transaction, Dunn directly owns 91,211 shares of NAII common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grant of restricted stock is a standard practice and suggests confidence in the company's future performance. The vesting schedule promotes long-term alignment.

Positives

  • The grant of restricted stock aligns the director's interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the director.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

  • The grant of restricted stock to a director can positively impact shareholders by aligning management's interests with theirs.
  • Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
03/07/2025Date of transaction: Alan G. Dunn acquired 8,000 shares of restricted stock.
03/07/2026Vesting date for one-third (2,667 shares) of the restricted stock.
03/07/2027Vesting date for one-third (2,667 shares) of the restricted stock.
03/07/2028Vesting date for the final third (2,666 shares) of the restricted stock.
03/11/2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.